Status:
COMPLETED
Observatory of Pulmonary Arterial Hypertension of Congenital Heart Disease
Lead Sponsor:
French Cardiology Society
Conditions:
Pulmonary Arterial Hypertension of Congenital Heart Disease
Eligibility:
All Genders
1+ years
Brief Summary
The complex congenital cardiac malformations are a significant number of different diseases, each having specific natural histories. The interface with pulmonary arterial hypertension (HTAP) is high s...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The patient has a congenital heart disease other than patent foramen ovale
- The diagnosis of pulmonary hypertension was confirmed by cardiac catheterization. Only patients with Eisenmenger syndrome can be included without catheterization.
- The catheterization was done after 1 January 2009
- A mean pulmonary artery pressure \> 25 mm Hg
- Pulmonary vascular resistances \> 3 piece Wood m2
- Pulmonary capillary pressure available
- Consent for inclusion in the study must be signed by parents or legal guardians for minors, by the patient for adults.
- The patient he had a surgical procedure or interventional catheterization cardiac catheterization between his diagnosis and inclusion in the observatory? If yes, it can only be included if a new catheterization confirmed the persistence of HTAP at least 6 months after the procedure.
- Patient follow-up (at least once a year) in the center for its HTAP associated with congenital heart disease its
Exclusion
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
349 Patients enrolled
Trial Details
Trial ID
NCT02260362
Start Date
October 1 2014
End Date
July 31 2022
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Necker Enfants Malades
Paris, France